Publisher： Adis International
ISSN： 1172-0360
Source： Drugs & Therapy Perspectives, Vol.26, Iss.3, 2010-03, pp. : 9-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Is Lithium Still the Maintenance Treatment of Choice for Bipolar Disorder?
CNS Drugs, Vol. 14, Iss. 2, 2000-08 ,pp. :
Oxaliplatin plus irinotecan seems highly promising as a first-line treatment option
Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. :
Efavirenz – Still First-line King?
By Best Brookie M Goicoechea Miguel
Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 7, 2008-07 ,pp. :
Neuroprotective Effects of Lithium in Patients with Bipolar Disorder
Current Psychopharmacology, Vol. 4, Iss. 2, 2016-02 ,pp. :